The case highlights how bradykinin-mediated angioedema can mimic severe allergic reactions and underscores the importance of complement testing and multidisciplinary review in patients with atypical or treatment-resistant anaphylaxis, as bradykinin-mediated angioedema does not respond to adrenaline, antihistamines, or corticosteroids. Here, KNG1 is linked to anaphylaxis.